Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_10578 | 11 | 0.24 | Mlig455_063647 | Neo: - Age: - |
Mlig455_063647 {REF} {Length: 394} {NoTransDecoderORF} {RNA1310_102533} {RNA815_12221} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | - | - | - | - | |
RegionR2 | - | - | - | - | |
RegionR3 | - | - | - | - | |
RegionR4 | - | - | - | - | |
RegionR5 | - | - | - | - | |
RegionR6 | - | - | - | - | |
RegionR7 | - | - | - | - | |
RegionR8 | - | - | - | - |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | - | - | - | - | |
RegenerationR2 | - | - | - | - | |
RegenerationR3 | - | - | - | - | |
RegenerationR4 | - | - | - | - | |
RegenerationR5 | - | - | - | - | |
RegenerationR6 | - | - | - | - | |
RegenerationBL | - | - | - | - | |
RegenerationTP | - | - | - | - |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_10578 | 11 | 0.24 | Mlig455_063647 | Neo: - Age: - |
3 | - | 1.000 | - | - | 1.000 | 1.000 | Mlig455_063647 {REF} {Length: 394} {NoTransDecoderORF} {RNA1310_102533} {RNA815_12221} | |
2. | MligTC455_33853 | 7 | 0.14 | Mlig455_029940 | Neo: - Age: - |
MGAT1 | 1.903 | - | 0.970 | - | - | 0.933 | - | Mlig455_029940 {REF} {Length: 2088} {Pfam: GNT-I family [PF03071.17, score=204.9]} {Human: ENSG00000131446, MGAT1, mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase, [Score=153, Expect=4e-41]} {Mouse: ENSMUSG00000020346, Mgat1, mannoside acetylglucosaminyltransferase 1, [Score=166, Expect=4e-46]} {Dmel: FBgn0034521, Mgat1, Mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase 1, [Score=172, Expect=3e-48]} {Celegans: WBGene00001639, gly-14, GLYcosylation related; UDP-N-acetylglucosamine:a-3-D-mannoside b-1,2-N-acetylglucosaminyltransferase I, [Score=144, Expect=2e-38]} {Smed: dd_Smed_v6_13024_0_1, dd_Smed_v6_13024_0_1, [Score=158, Expect=1e-43]} {RNA1310_114996} |
3. | MligTC455_13395 | 18 | 0.38 | Mlig455_061750 | Neo: - Age: - |
QRFPR | 1.888 | - | 0.957 | - | - | 0.931 | - | Mlig455_061750 {REF} {Length: 1579} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=107.1]} {Human: ENSG00000186867, QRFPR, pyroglutamylated RFamide peptide receptor, [Score=99.8, Expect=2e-22]} {Mouse: ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=92.8, Expect=2e-20]} {Dmel: FBgn0050106, CCHa1-R, CCHamide-1 receptor, [Score=78.6, Expect=1e-15]} {Celegans: WBGene00021983, npr-5, NeuroPeptide Receptor family, [Score=77.4, Expect=2e-15]} {Smed: dd_Smed_v6_14520_0_1, dd_Smed_v6_14520_0_1, [Score=73.9, Expect=2e-14]} {RNA1310_103173} {RNA815_39338} |
4. | MligTC455_33850 | 80 | 1.67 | Mlig455_015720 | Neo: - Age: - Region-enriched R2: 4.134/0.00338 |
1.805 | - | 0.950 | - | - | - | 0.855 | Mlig455_015720 {REF} {Length: 829} {RNA1509_37932} {RNA1310_98453} | |
5. | MligTC455_14126 | 1888 | 39.32 | Mlig455_031057 | Neo: Irradiation Age: Up-Down-Down, logFC(26M/2M)=-1.763 Region-specific R2: 6.685 Region-enriched R2: 8.246/0.00000 Regeneration-downregulated R2: -3.933 Regeneration-depleted R2: -3.933 |
SSPO | 1.758 | - | 0.790 | - | - | 0.968 | - | Mlig455_031057 {REF} {Length: 3178} {Pfam: Spondin-like TSP1 domain [PF19028.2, score=118.7]; Thrombospondin type 1 domain [PF00090.21, score=76.9]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=46.2]; CCN3 Nov like TSP1 domain [PF19035.2, score=19.7]} {Human: ENSG00000197558, SSPO, SCO-spondin, [Score=115, Expect=2e-25]} {Mouse: ENSMUSG00000029797, Sspo, SCO-spondin, [Score=113, Expect=9e-25]} {Dmel: FBgn0026721, fat-spondin, [Score=65.5, Expect=2e-10]} {Celegans: WBGene00006893, spon-1, SPONdin (Extracellular matrix glycoprotein) family, [Score=74.3, Expect=3e-13]} {Smed: dd_Smed_v6_628_0_1, dd_Smed_v6_628_0_1, [RH, Score=487, Expect=3e-156]} {RNA1509_2451} {RNA1310_3554.1} {RNA815_1109} |
6. | MligTC455_36371 | 1892 | 39.41 | Mlig455_005636 | Neo: - Age: Down-Down-Up Region-enriched R2: 7.119/0.00007 |
C6orf120 | 1.749 | - | 0.784 | - | - | 0.965 | - | Mlig455_005636 {REF} {Length: 4589} {TRANSSPLICED} {Pfam: Putative cytokine, C6ORF120 [PF17065.7, score=46.3]} {Human: ENSG00000185127, C6orf120, chromosome 6 open reading frame 120, [Score=52.8, Expect=5e-08]} {Mouse: ENSMUSG00000050088, 1600012H06Rik, RIKEN cDNA 1600012H06 gene, [Score=52.4, Expect=5e-08]} {RNA1509_33302, RNA1509_46654} {RNA1310_15958, RNA1509_46654} {RNA1509_46654, RNA815_10779} |
7. | MligTC455_36372 | 925 | 19.28 | Mlig455_005680 | Neo: - Age: logFC(26M/2M)=2.101 Region-enriched R2: 7.233/0.00006 |
1.731 | - | 0.764 | - | - | 0.967 | - | Mlig455_005680 {REF} {Length: 1993} {RNA1509_18409, RNA1509_31432} {RNA1310_82233, RNA1509_18409, RNA1509_31432} {RNA1509_18409, RNA1509_31432, RNA815_42934} | |
8. | MligTC455_16143 | 44 | 0.92 | Mlig455_066144 | Neo: - Age: - |
1.722 | - | 0.957 | - | - | 0.765 | - | Mlig455_066144 {REF} {Length: 1180} {NoTransDecoderORF} {RNA1310_45498} {RNA815_15412} | |
9. | MligTC455_47254 | 846 | 17.62 | Mlig455_043914 | Neo: - Age: - Region-enriched R8: 1.811/0.01369 |
1.717 | - | 0.760 | - | - | 0.957 | - | Mlig455_043914 {REF} {Length: 2393} {Pfam: Fibronectin type II domain [PF00040.21, score=49.6]} {Dmel: FBgn0013733, shot, short stop, [Score=48.5, Expect=7e-06]} {RNA1509_15863, RNA1509_55479} {RNA1310_23604.1, RNA1509_15863, RNA1509_55479} {RNA1509_15863, RNA1509_55479, RNA815_10284} | |
10. | MligTC455_14125 | 432 | 9.01 | Mlig455_031050 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-1.941 Region-specific R2: 7.318 Region-enriched R2: 7.339/0.00000 |
OTOG | 1.711 | - | 0.757 | - | - | 0.954 | - | Mlig455_031050 {REF} {Length: 2951} {Pfam: Spondin-like TSP1 domain [PF19028.2, score=32.8]; Pacifastin inhibitor (LCMII) [PF05375.15, score=25.4]} {Human: ENSG00000188162, OTOG, otogelin, [Score=49.3, Expect=6e-06]} {Mouse: ENSMUSG00000029797, Sspo, SCO-spondin, [Score=53.9, Expect=1e-07]} {Smed: dd_Smed_v6_628_0_1, dd_Smed_v6_628_0_1, [Score=117, Expect=3e-29]} {RNA1509_2451} {RNA1310_3554.1} {RNA815_1109} |
11. | MligTC455_40482 | 206 | 4.3 | Mlig455_035109, Mlig455_062419 | Neo: - Age: - |
1.7 | - | 0.747 | - | - | 0.953 | - | Mlig455_035109 {REF} {Length: 1527} {Pfam: emp24/gp25L/p24 family/GOLD [PF01105.26, score=20.2]} {RNA1509_41958} {RNA1310_29720, RNA1509_41958} {RNA1509_41958, RNA815_13581.1} Mlig455_062419 {REF} {Length: 1210} {Pfam: emp24/gp25L/p24 family/GOLD [PF01105.26, score=20.4]} {RNA1509_41958} {RNA1310_29720} {RNA815_13581.1} |
|
12. | MligTC455_37025 | 209 | 4.34 | Mlig455_029443 | Neo: - |
0.992 | - | - | - | - | 0.992 | - | Mlig455_029443 {REF} {Length: 893} {RNA1310_43520} {RNA815_2407} | |
13. | MligTC455_46046 | 18 | 0.37 | Mlig455_042344 | Neo: - Age: - |
ASL | 0.992 | - | - | - | - | 0.992 | - | Mlig455_042344 {REF} {Length: 1218} {Pfam: Lyase [PF00206.22, score=41.7]; WSC domain [PF01822.21, score=31.1]} {Human: ENSG00000126522, ASL, argininosuccinate lyase, [Score=77.8, Expect=4e-16]} {Mouse: ENSMUSG00000025533, Asl, argininosuccinate lyase, [Score=76.3, Expect=8e-16]} {Dmel: FBgn0032076, CG9510, [Score=70.5, Expect=6e-14]} {Smed: dd_Smed_v6_3792_0_1, dd_Smed_v6_3792_0_1, [Score=86.7, Expect=9e-20]} {RNA1509_17568} {RNA1310_77268} {RNA815_37535} |
14. | MligTC455_22429 | 49 | 1.02 | Mlig455_011037 | Neo: - Age: - |
0.99 | - | 0.990 | - | - | - | - | Mlig455_011037 {REF} {Length: 3888} {Pfam: WS/DGAT C-terminal domain [PF06974.15, score=54.7]; ZIP Zinc transporter [PF02535.24, score=18.9]; Transcriptional regulator of RNA polII, SAGA, subunit [PF12767.9, score=18.7]; Eukaryotic translation initiation factor 3 subunit 7 (eIF-3) [PF05091.14, score=18.2]} {Smed: dd_Smed_v6_7004_0_1, dd_Smed_v6_7004_0_1, [Score=150, Expect=6e-37]} {RNA1310_98904} | |
15. | MligTC455_10606 | 30 | 0.63 | Mlig455_005665 | Neo: - Age: - |
0.988 | - | - | - | - | 0.988 | - | Mlig455_005665 {REF} {Length: 878} {RNA1310_38644} {RNA815_26421} | |
16. | MligTC455_12359 | 34 | 0.71 | Mlig455_036860, Mlig455_053000 | Neo: - Age: - |
0.986 | - | - | - | - | 0.986 | - | Mlig455_036860 {REF} {Length: 2052} {Pfam: Ammonium Transporter Family [PF00909.23, score=351.9]} {Dmel: FBgn0038309, Amt, Ammonium transporter, [Score=177, Expect=1e-48]} {Celegans: WBGene00000136, amt-4, Ammonium transporter, [Score=361, Expect=7e-119]} {RNA1310_63464} {RNA815_52017} Mlig455_053000 {REF} {Length: 2052} {Pfam: Ammonium Transporter Family [PF00909.23, score=351.9]} {Dmel: FBgn0038309, Amt, Ammonium transporter, [Score=177, Expect=1e-48]} {Celegans: WBGene00000136, amt-4, Ammonium transporter, [Score=361, Expect=7e-119]} {RNA1310_63464} {RNA815_52017} |
|
17. | MligTC455_22786 | 673 | 14.02 | Mlig455_026980, Mlig455_030714 | Neo: - Age: - |
PCBP3 | 0.985 | - | - | - | - | 0.985 | - | Mlig455_026980 {REF} {Length: 4441} {Pfam: KH domain [PF00013.31, score=173.6]; KH domain [PF07650.19, score=54.2]; KH domain [PF13083.8, score=32.1]; KH-like RNA-binding domain [PF16005.7, score=24.8]} {Human: ENSG00000183570, PCBP3, poly(rC) binding protein 3, [Score=311, Expect=5e-100]} {Mouse: ENSMUSG00000001120, Pcbp3, poly(rC) binding protein 3, [RH, Score=234, Expect=8e-73]; ENSMUSG00000056851, Pcbp2, poly(rC) binding protein 2, [RH, Score=229, Expect=3e-70]} {Dmel: FBgn0262737, mub, mushroom-body expressed, [Score=211, Expect=2e-62]} {Celegans: WBGene00003978, pes-4, Patterned Expression Site, [RH, Score=233, Expect=6e-70]} {Smed: dd_Smed_v6_8431_0_1, dd_Smed_v6_8431_0_1, [Score=270, Expect=7e-83]} {RNA1509_19682} {RNA1310_2287.1, RNA1509_19682} {RNA1509_19682, RNA815_8711.1} Mlig455_030714 {REF} {Length: 4400} {Pfam: KH domain [PF00013.31, score=173.6]; KH domain [PF07650.19, score=54.3]; KH domain [PF13083.8, score=32.1]; KH-like RNA-binding domain [PF16005.7, score=24.8]} {Human: ENSG00000183570, PCBP3, poly(rC) binding protein 3, [Score=310, Expect=9e-100]} {Mouse: ENSMUSG00000001120, Pcbp3, poly(rC) binding protein 3, [RH, Score=234, Expect=7e-73]; ENSMUSG00000056851, Pcbp2, poly(rC) binding protein 2, [RH, Score=228, Expect=3e-70]} {Dmel: FBgn0262737, mub, mushroom-body expressed, [Score=211, Expect=3e-62]} {Celegans: WBGene00003978, pes-4, Patterned Expression Site, [RH, Score=233, Expect=6e-70]} {Smed: dd_Smed_v6_8431_0_1, dd_Smed_v6_8431_0_1, [Score=270, Expect=5e-83]} {RNA1509_19682} {RNA1310_6582} {RNA815_9331} |
18. | MligTC455_24108 | 17 | 0.35 | Mlig455_019116 | Neo: - Age: - |
KCNK16 | 0.983 | - | - | - | - | 0.983 | - | Mlig455_019116 {REF} {Length: 1389} {Pfam: Ion channel [PF07885.18, score=118.0]; Ion transport protein [PF00520.33, score=29.1]} {Human: ENSG00000095981, KCNK16, potassium two pore domain channel subfamily K member 16, [Score=155, Expect=5e-44]} {Mouse: ENSMUSG00000023243, Kcnk5, potassium channel, subfamily K, member 5, [RH, Score=141, Expect=3e-37]} {Dmel: FBgn0037690, Task7, TWIK-related acid-sensitive K[+] channel 7, [Score=110, Expect=3e-27]} {Celegans: WBGene00006696, twk-46, TWiK family of potassium channels, [Score=115, Expect=3e-29]} {Smed: dd_Smed_v6_9028_0_1, dd_Smed_v6_9028_0_1, [Score=121, Expect=4e-31]} {RNA1310_125949} |
19. | MligTC455_44613 | 879 | 18.31 | Mlig455_049755 | Neo: - Age: - Region-enriched R3: 3.382/0.00001 |
0.982 | - | - | - | - | 0.982 | - | Mlig455_049755 {REF} {Length: 593} {RNA1509_14010, RNA1509_30662} {RNA1310_67855.1, RNA1509_14010, RNA1509_30662} {RNA1509_14010, RNA1509_30662, RNA815_34213.1} | |
20. | MligTC455_14123 | 49 | 1.01 | Mlig455_004226, Mlig455_031058 | Neo: - |
MUC17 | 0.98 | - | - | - | - | 0.980 | - | Mlig455_004226 {REF} {Length: 15360} {Pfam: Spondin-like TSP1 domain [PF19028.2, score=143.9]; Thrombospondin type 1 domain [PF00090.21, score=83.9]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=40.0]} {Human: ENSG00000169876, MUC17, mucin 17, cell surface associated, [Score=86.7, Expect=8e-16]; ENSG00000143341, HMCN1, hemicentin 1, [Score=85.5, Expect=2e-15]} {Mouse: ENSMUSG00000099398, Ms4a14, membrane-spanning 4-domains, subfamily A, member 14, [Score=94.4, Expect=2e-18]} {Dmel: FBgn0026721, fat-spondin, [Score=55.1, Expect=1e-06]} {Celegans: WBGene00006893, spon-1, SPONdin (Extracellular matrix glycoprotein) family, [Score=72.8, Expect=4e-12]} {Smed: dd_Smed_v6_628_0_1, dd_Smed_v6_628_0_1, [RH, Score=419, Expect=8e-124]} {RNA1509_2451} {RNA1310_3554.1} {RNA815_1109} Mlig455_031058 {REF} {Length: 19314} {Human: ENSG00000169876, MUC17, mucin 17, cell surface associated, [Score=81.3, Expect=4e-14]} {RNA1509_11979, RNA1509_13470, RNA1509_1397, RNA1509_22985, RNA1509_30738, RNA1509_34825, RNA1509_53938, RNA1509_54748, RNA1509_58409, RNA1509_59378, RNA1509_6442, RNA1509_6612} {RNA1310_16813.1, RNA1509_13470, RNA1509_1397, RNA1509_22985, RNA1509_30738, RNA1509_34825, RNA1509_53938, RNA1509_54748, RNA1509_58409, RNA1509_59378, RNA1509_6442, RNA1509_6612} {RNA1509_13470, RNA1509_1397, RNA1509_22985, RNA1509_30738, RNA1509_34825, RNA1509_53938, RNA1509_54748, RNA1509_58409, RNA1509_59378, RNA1509_6442, RNA1509_6612, RNA815_1331} |
21. | MligTC455_10918 | 422 | 8.79 | Mlig455_047587, Mlig455_047602 | Neo: - Age: - |
ASIC2 | 0.979 | - | - | - | - | 0.979 | - | Mlig455_047587 {REF} {Length: 2857} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=295.2]} {Human: ENSG00000108684, ASIC2, acid sensing ion channel subunit 2, [RH, Score=139, Expect=2e-34]; ENSG00000110881, ASIC1, acid sensing ion channel subunit 1, [RH, Score=133, Expect=9e-33]} {Mouse: ENSMUSG00000020704, Asic2, acid-sensing (proton-gated) ion channel 2, [RH, Score=137, Expect=3e-34]; ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [RH, Score=137, Expect=4e-34]} {Dmel: FBgn0052792, ppk8, pickpocket 8, [RH, Score=65.9, Expect=5e-11]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [RH, Score=162, Expect=2e-43]} {Smed: dd_Smed_v6_11787_0_1, dd_Smed_v6_11787_0_1, [Score=387, Expect=3e-129]} {RNA1509_23163} {RNA1310_6510} {RNA815_3823} Mlig455_047602 {REF} {Length: 2812} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=295.2]} {Human: ENSG00000108684, ASIC2, acid sensing ion channel subunit 2, [RH, Score=139, Expect=2e-34]; ENSG00000110881, ASIC1, acid sensing ion channel subunit 1, [RH, Score=133, Expect=9e-33]} {Mouse: ENSMUSG00000020704, Asic2, acid-sensing (proton-gated) ion channel 2, [RH, Score=137, Expect=3e-34]; ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [RH, Score=137, Expect=4e-34]} {Dmel: FBgn0052792, ppk8, pickpocket 8, [RH, Score=65.9, Expect=5e-11]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [RH, Score=162, Expect=2e-43]} {Smed: dd_Smed_v6_11787_0_1, dd_Smed_v6_11787_0_1, [Score=387, Expect=3e-129]} {RNA1509_23163} {RNA1310_6510, RNA1509_23163} {RNA1509_23163, RNA815_3823} |
22. | MligTC455_48040 | 27 | 0.56 | Mlig455_030996, Mlig455_069430 | Neo: - Age: - |
0.979 | - | - | - | - | 0.979 | - | Mlig455_030996 {REF} {Length: 1439} {RNA1310_28432} {RNA815_8574} Mlig455_069430 {REF} {Length: 1659} {RNA1509_58583} {RNA1310_28432} {RNA815_8574} |
|
23. | MligTC455_46045 | 6 | 0.13 | Mlig455_042339 | Neo: - Age: - |
ASL | 0.978 | - | - | - | - | 0.978 | - | Mlig455_042339 {REF} {Length: 1282} {Pfam: Lyase [PF00206.22, score=45.9]; WSC domain [PF01822.21, score=43.7]; PAN domain [PF00024.28, score=20.6]} {Human: ENSG00000126522, ASL, argininosuccinate lyase, [Score=79.0, Expect=1e-16]} {Mouse: ENSMUSG00000025533, Asl, argininosuccinate lyase, [Score=77.0, Expect=3e-16]} {Dmel: FBgn0032076, CG9510, [Score=68.2, Expect=3e-13]} {Smed: dd_Smed_v6_3792_0_1, dd_Smed_v6_3792_0_1, [Score=80.9, Expect=6e-18]} {RNA1509_17568} {RNA1310_77268} {RNA815_37535} |
24. | MligTC455_53657 | 221 | 4.6 | Mlig455_039396 | Neo: - Age: - Region-enriched R2: 6.078/0.00340 |
0.978 | - | 0.978 | - | - | - | - | Mlig455_039396 {REF} {Length: 1026} {Pfam: emp24/gp25L/p24 family/GOLD [PF01105.26, score=21.0]} {RNA1509_40972} {RNA1310_35649.1, RNA1509_40972} {RNA1509_40972, RNA815_17004} | |
25. | MligTC455_05051 | 12 | 0.24 | Mlig455_027802 | Neo: - Age: - |
0.975 | - | - | - | - | 0.975 | - | Mlig455_027802 {REF} {Length: 2094} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=43.7]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=23.8]} {Celegans: WBGene00015323, frpr-1, Probable G-protein coupled receptor frpr-1, [Score=53.9, Expect=8e-08]} {Smed: dd_Smed_v6_19397_0_1, dd_Smed_v6_19397_0_1, [Score=89.0, Expect=3e-19]} {RNA1310_29651} {RNA815_43873} | |
26. | MligTC455_44751 | 106 | 2.22 | Mlig455_070696 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.858 Region-enriched R3: 5.633/0.00003 |
0.975 | - | - | - | - | 0.975 | - | Mlig455_070696 {REF} {Length: 1353} {tRNA: Val(CAC), score=80.9} {Pfam: emp24/gp25L/p24 family/GOLD [PF01105.26, score=22.9]} {RNA1509_24847, RNA1509_44317} {RNA1310_32778, RNA1509_24847, RNA1509_44317} {RNA1509_24847, RNA1509_44317, RNA815_15818} | |
27. | MligTC455_51262 | 384 | 7.99 | Mlig455_036989 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.021 Region-enriched R3: 4.958/0.00000 |
0.975 | - | - | - | - | 0.975 | - | Mlig455_036989 {REF} {Length: 1396} {Pfam: Universal stress protein family [PF00582.28, score=85.7]} {Smed: dd_Smed_v6_402_1_1, dd_Smed_v6_402_1_1, [Score=97.4, Expect=8e-26]} {RNA1310_30400} {RNA815_28361} | |
28. | MligTC455_16781 | 32 | 0.67 | Mlig455_003020, Mlig455_003313 | Neo: - Age: - |
0.973 | - | - | - | - | 0.973 | - | Mlig455_003020 {REF} {Length: 518} {Pfam: Immunoreceptor tyrosine-based activation motif [PF02189.17, score=26.8]} {RNA1310_57787} {RNA815_49158} Mlig455_003313 {REF} {Length: 905} {Pfam: Immunoreceptor tyrosine-based activation motif [PF02189.17, score=74.4]} {RNA1310_57787} {RNA815_49158} |
|
29. | MligTC455_01157 | 3 | 0.07 | Mlig455_018526 | Neo: - Age: - |
0.972 | - | - | - | - | 0.972 | - | Mlig455_018526 {REF} {Length: 119} {NoTransDecoderORF} | |
30. | MligTC455_09115 | 8 | 0.17 | Mlig455_062552 | Neo: - Age: - |
0.972 | - | - | - | - | 0.972 | - | Mlig455_062552 {REF} {Length: 2058} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=143.1]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=57.8, Expect=1e-08]} {Smed: dd_Smed_v6_15195_0_1, dd_Smed_v6_15195_0_1, [Score=52.0, Expect=6e-07]} {RNA1310_85150} {RNA815_45687} | |
31. | MligTC455_53936 | 24 | 0.5 | Mlig455_021898 | Neo: - Age: - |
0.972 | - | - | - | - | 0.972 | - | Mlig455_021898 {REF} {Length: 737} {NoTransDecoderORF} {RNA1310_130902} | |
32. | MligTC455_24270 | 71 | 1.47 | Mlig455_005120 | Neo: - Age: - |
CHRNA7 | 0.971 | - | 0.971 | - | - | - | - | Mlig455_005120 {REF} {Length: 1530} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=115.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=66.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=148, Expect=4e-39]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=147, Expect=5e-39]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=4e-38]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=146, Expect=2e-38]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=140, Expect=1e-36]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=135, Expect=5e-34]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=134, Expect=9e-35]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=133, Expect=4e-34]} {RNA1509_43533} {RNA1310_20839.2} {RNA815_22406} |
33. | MligTC455_52926 | 9 | 0.18 | Mlig455_024897 | Neo: - Age: - |
0.971 | - | 0.971 | - | - | - | - | Mlig455_024897 {REF} {Length: 428} {NoTransDecoderORF} {RNA1310_119495} | |
34. | MligTC455_05537 | 3 | 0.06 | Mlig455_033428 | Neo: - Age: - |
0.97 | - | - | - | - | 0.970 | - | Mlig455_033428 {REF} {Length: 524} {TRANSSPLICED} {Pfam: Homeodomain-like domain [PF13565.8, score=33.9]; Winged helix-turn helix [PF13551.8, score=26.5]} {RNA1310_101187} | |
35. | MligTC455_09196 | 28 | 0.59 | Mlig455_046836 | Neo: - Age: - |
0.97 | - | - | - | - | 0.970 | - | Mlig455_046836 {REF} {Length: 3502} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=187.1]} {Mouse: ENSMUSG00000028008, Asic5, acid-sensing (proton-gated) ion channel family member 5, [Score=55.1, Expect=2e-07]} {Celegans: WBGene00006832, unc-105, Degenerin-like protein unc-105, [Score=62.4, Expect=9e-10]} {Smed: dd_Smed_v6_8949_0_1, dd_Smed_v6_8949_0_1, [Score=75.1, Expect=6e-14]} {RNA1509_28410} {RNA1310_44135} {RNA815_33213} | |
36. | MligTC455_12978 | 63 | 1.31 | Mlig455_023948 | Neo: - Age: - |
0.97 | - | 0.970 | - | - | - | - | Mlig455_023948 {REF} {Length: 2929} {RNA1310_80095.1} | |
37. | MligTC455_14752 | 17 | 0.36 | Mlig455_009102 | Neo: - Age: - |
0.97 | - | - | - | - | 0.970 | - | Mlig455_009102 {REF} {Length: 1690} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=50.9]; Capsular polysaccharide synthesis protein [PF05704.14, score=18.3]} {Smed: dd_Smed_v6_9783_0_1, dd_Smed_v6_9783_0_1, [Score=89.7, Expect=1e-19]} {RNA1509_4484} {RNA1310_25467} {RNA815_39314} | |
38. | MligTC455_19225 | 26 | 0.54 | Mlig455_018507 | Neo: - Age: - |
SCNN1B | 0.97 | - | 0.970 | - | - | - | - | Mlig455_018507 {REF} {Length: 2590} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=142.8]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=59.3, Expect=1e-08]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=60.8, Expect=1e-09]} {Smed: dd_Smed_v6_17245_0_1, dd_Smed_v6_17245_0_1, [Score=49.3, Expect=5e-06]} {RNA1509_52685} {RNA1310_32081} {RNA815_49764} |
39. | MligTC455_23833 | 17 | 0.36 | Mlig455_016419 | Neo: - Age: - |
MYT1 | 0.97 | - | 0.970 | - | - | - | - | Mlig455_016419 {REF} {Length: 2682} {Pfam: Zinc finger, C2HC type [PF01530.20, score=79.8]} {Human: ENSG00000196132, MYT1, myelin transcription factor 1, [RH, Score=131, Expect=5e-32]; ENSG00000276876, MYT1, myelin transcription factor 1, [RH, Score=131, Expect=5e-32]; ENSG00000275018, AL121581.1, novel transcript, [RH, Score=130, Expect=1e-31]; ENSG00000147488, ST18, ST18, C2H2C-type zinc finger, [RH, Score=125, Expect=3e-30]} {Mouse: ENSMUSG00000010505, Myt1, myelin transcription factor 1, [RH, Score=132, Expect=6e-33]; ENSMUSG00000061911, Myt1l, myelin transcription factor 1-like, [RH, Score=129, Expect=1e-31]; ENSMUSG00000033740, St18, suppression of tumorigenicity 18, [RH, Score=126, Expect=2e-30]} {Dmel: FBgn0263772, CG43689, [RH, Score=99.0, Expect=1e-21]} {Celegans: WBGene00009939, ztf-11, Zinc finger putative Transcription Factor family, [RH, Score=121, Expect=1e-29]} {Smed: dd_Smed_v6_80183_0_2, dd_Smed_v6_80183_0_2, [Score=127, Expect=4e-34]} {RNA1310_143021} |
40. | MligTC455_50781 | 17 | 0.35 | Mlig455_012010 | Neo: - Age: - |
HTR4 | 0.97 | - | - | - | - | 0.970 | - | Mlig455_012010 {REF} {Length: 2944} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=230.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=58.2]; 7tm Chemosensory receptor [PF08395.14, score=19.8]} {Human: ENSG00000164270, HTR4, 5-hydroxytryptamine receptor 4, [RH, Score=219, Expect=4e-67]; ENSG00000184845, DRD1, dopamine receptor D1, [RH, Score=214, Expect=3e-64]} {Mouse: ENSMUSG00000026322, Htr4, 5 hydroxytryptamine (serotonin) receptor 4, [RH, Score=226, Expect=9e-70]} {Dmel: FBgn0038063, Octbeta2R, Octopamine beta2 receptor, [RH, Score=331, Expect=1e-107]} {Celegans: WBGene00001052, dop-1, DOPamine receptor, [Score=181, Expect=9e-53]} {Smed: dd_Smed_v6_13756_0_1, dd_Smed_v6_13756_0_1, [RH, Score=353, Expect=2e-119]} {RNA1310_126774} |
41. | MligTC455_18139 | 70 | 1.45 | Mlig455_010809 | Neo: - Age: logFC(26M/2M)=-0.809 Region-enriched R2: 6.868/0.00081 |
TRPC5 | 0.968 | - | 0.968 | - | - | - | - | Mlig455_010809 {REF} {Length: 4442} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.1]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.4]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=740, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=744, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=740, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=694, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1017, Expect=0.0]} {RNA1509_34138} {RNA1310_12839, RNA1509_34138} {RNA1509_34138, RNA815_17637} |
42. | MligTC455_36567 | 18 | 0.37 | Mlig455_065030 | Neo: - Age: - |
0.968 | - | 0.968 | - | - | - | - | Mlig455_065030 {REF} {Length: 672} | |
43. | MligTC455_42297 | 613 | 12.76 | Mlig455_056779 | Neo: - Age: Down-Down-Up Region-enriched R3: 6.339/0.00000 |
0.968 | - | - | - | - | 0.968 | - | Mlig455_056779 {REF} {Length: 452} {RNA1509_13422} {RNA1310_77804} {RNA815_39955} | |
44. | MligTC455_14005 | 8 | 0.16 | Mlig455_035936 | Neo: - Age: - |
0.967 | - | - | - | - | 0.967 | - | Mlig455_035936 {REF} {Length: 3711} {TRANSSPLICED} {Pfam: Small metal-binding protein [PF16785.7, score=26.4]; Baculovirus polyhedron envelope protein, PEP, C terminus [PF04513.14, score=22.2]; Protein of unknown function (DUF1664) [PF07889.14, score=19.3]} {RNA1509_9022} {RNA1310_85664} | |
45. | MligTC455_49939 | 28 | 0.58 | Mlig455_010579 | Neo: - Age: - |
GALNT1 | 0.967 | - | - | - | - | 0.967 | - | Mlig455_010579 {REF} {Length: 2403} {Pfam: Glycosyl transferase family 2 [PF00535.28, score=94.3]} {Human: ENSG00000141429, GALNT1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=246, Expect=3e-75]; ENSG00000136542, GALNT5, polypeptide N-acetylgalactosaminyltransferase 5, [Score=245, Expect=8e-72]; ENSG00000144278, GALNT13, polypeptide N-acetylgalactosaminyltransferase 13, [Score=243, Expect=7e-74]; ENSG00000164574, GALNT10, polypeptide N-acetylgalactosaminyltransferase 10, [Score=241, Expect=8e-73]; ENSG00000178234, GALNT11, polypeptide N-acetylgalactosaminyltransferase 11, [Score=238, Expect=2e-71]; ENSG00000115339, GALNT3, polypeptide N-acetylgalactosaminyltransferase 3, [Score=237, Expect=7e-71]} {Mouse: ENSMUSG00000026828, Galnt5, polypeptide N-acetylgalactosaminyltransferase 5, [Score=253, Expect=5e-75]; ENSMUSG00000026994, Galnt3, polypeptide N-acetylgalactosaminyltransferase 3, [Score=250, Expect=5e-76]; ENSMUSG00000000420, Galnt1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=248, Expect=6e-76]; ENSMUSG00000060988, Galnt13, polypeptide N-acetylgalactosaminyltransferase 13, [Score=242, Expect=7e-74]; ENSMUSG00000020520, Galnt10, polypeptide N-acetylgalactosaminyltransferase 10, [Score=241, Expect=7e-73]} {Dmel: FBgn0050463, CG30463, [Score=292, Expect=3e-92]} {Celegans: WBGene00001630, gly-5, Polypeptide N-acetylgalactosaminyltransferase 5, [Score=303, Expect=9e-97]} {Smed: dd_Smed_v6_4615_0_1, dd_Smed_v6_4615_0_1, [Score=339, Expect=7e-111]} {RNA1310_80255} |
46. | MligTC455_08098 | 15 | 0.31 | Mlig455_029099 | Neo: - Age: - Region-enriched R2: 8.013/0.00338 |
0.966 | - | 0.966 | - | - | - | - | Mlig455_029099 {REF} {Length: 1334} {RNA1310_58776} {RNA815_46110} | |
47. | MligTC455_08281 | 4 | 0.08 | Mlig455_026221 | Neo: - Age: - |
0.966 | - | - | - | - | 0.966 | - | Mlig455_026221 {REF} {Length: 717} {NoTransDecoderORF} {RNA1310_112642} {RNA815_61497} | |
48. | MligTC455_08408 | 41 | 0.86 | Mlig455_043171 | Neo: - Age: Up-Down-Down |
0.966 | - | 0.966 | - | - | - | - | Mlig455_043171 {REF} {Length: 1568} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.4]} {RNA1310_47844} {RNA815_49360} | |
49. | MligTC455_08763 | 20 | 0.41 | Mlig455_061186 | Neo: - Age: - |
0.966 | - | 0.966 | - | - | - | - | Mlig455_061186 {REF} {Length: 1077} {Smed: dd_Smed_v6_13791_0_1, dd_Smed_v6_13791_0_1, [Score=96.3, Expect=3e-24]} {RNA1310_122132} | |
50. | MligTC455_09874 | 31 | 0.65 | Mlig455_045071 | Neo: - Age: - |
DOC2A | 0.966 | - | 0.966 | - | - | - | - | Mlig455_045071 {REF} {Length: 1760} {Pfam: C2 domain [PF00168.32, score=55.9]} {Human: ENSG00000149927, DOC2A, double C2 domain alpha, [Score=55.8, Expect=7e-08]} {Mouse: ENSMUSG00000052301, Doc2a, double C2, alpha, [Score=55.5, Expect=7e-08]} {Celegans: WBGene00004923, snt-3, SyNapTotagmin, [Score=70.5, Expect=2e-13]} {Smed: dd_Smed_v6_16731_0_1, dd_Smed_v6_16731_0_1, [Score=112, Expect=7e-27]} {RNA1310_36283} {RNA815_40844} |
51. | MligTC455_10229 | 24 | 0.49 | Mlig455_023615 | Neo: - Age: - |
0.966 | - | 0.966 | - | - | - | - | Mlig455_023615 {REF} {Length: 1635} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.2]} {RNA1310_22533.3} {RNA815_23050} | |
52. | MligTC455_10810 | 6 | 0.12 | Mlig455_069505 | Neo: - Age: - |
0.966 | - | 0.966 | - | - | - | - | Mlig455_069505 {REF} {Length: 376} {NoTransDecoderORF} {RNA1310_40761} | |
53. | MligTC455_11661 | 4 | 0.08 | Mlig455_019371, Mlig455_059103 | Neo: - Age: - |
0.966 | - | 0.966 | - | - | - | - | Mlig455_019371 {REF} {Length: 67} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_39490} {RNA1310_101865} {RNA815_41733} Mlig455_059103 {REF} {Length: 67} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_39490} {RNA1310_101865} {RNA815_41733} |
|
54. | MligTC455_13049 | 53 | 1.11 | Mlig455_029230, Mlig455_029252, Mlig455_035639, Mlig455_035735 | Neo: - Age: Down-Up-Down Region-enriched R2: 6.077/0.00215 |
HTR2A | 0.966 | - | 0.966 | - | - | - | - | Mlig455_029230 {REF} {Length: 2756} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=149.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=46.0]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=25.6]; Unstructured region C-term to UIM in Ataxin3 [PF16619.7, score=24.1]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=19.2]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=142, Expect=3e-37]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=141, Expect=5e-37]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=138, Expect=8e-36]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=131, Expect=1e-32]} {Celegans: WBGene00004776, ser-1, SERotonin/octopamine receptor family; Serotonin receptor, [Score=120, Expect=2e-29]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=281, Expect=8e-90]} {RNA1310_91864} Mlig455_029252 {REF} {Length: 2844} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=188.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=43.8]; Spt20 family [PF12090.10, score=21.4]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=144, Expect=2e-36]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=142, Expect=4e-36]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=140, Expect=1e-35]} {Dmel: FBgn0004514, Oct-TyrR, Octopamine-Tyramine receptor, [Score=136, Expect=2e-33]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=157, Expect=2e-41]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=336, Expect=4e-108]} {RNA1310_91864} Mlig455_035639 {REF} {Length: 2811} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=182.5]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=43.7]; Spt20 family [PF12090.10, score=24.8]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=144, Expect=2e-36]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=143, Expect=3e-36]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=141, Expect=1e-35]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=133, Expect=6e-32]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=156, Expect=5e-41]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=284, Expect=3e-88]} {RNA1310_91864} Mlig455_035735 {REF} {Length: 1469} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=140.9]; Spt20 family [PF12090.10, score=23.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=18.8]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=97.1, Expect=3e-21]; ENSG00000147246, HTR2C, 5-hydroxytryptamine receptor 2C, [Score=95.1, Expect=2e-20]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=95.5, Expect=1e-20]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=93.2, Expect=6e-20]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=89.0, Expect=2e-18]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=115, Expect=1e-27]} {Smed: dd_Smed_v6_31134_0_1, dd_Smed_v6_31134_0_1, [Score=249, Expect=4e-77]} {RNA1310_91864} |
55. | MligTC455_16248 | 132 | 2.74 | Mlig455_038325, Mlig455_050222, Mlig455_050231 | Neo: - Age: - |
CHRNA3 | 0.966 | - | 0.966 | - | - | - | - | Mlig455_038325 {REF} {Length: 1078} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=200.0]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=192, Expect=4e-57]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=194, Expect=7e-58]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=190, Expect=1e-56]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=206, Expect=1e-62]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=186, Expect=4e-55]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=216, Expect=5e-67]} {RNA1310_44575} {RNA815_22042} Mlig455_050222 {REF} {Length: 2164} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=202.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=197.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=348, Expect=5e-114]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=335, Expect=4e-109]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=348, Expect=2e-114]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=343, Expect=2e-112]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=335, Expect=5e-109]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=397, Expect=1e-133]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=338, Expect=2e-110]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=489, Expect=5e-170]} {RNA1310_44575} {RNA815_22042} Mlig455_050231 {REF} {Length: 2219} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=203.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=143.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=304, Expect=5e-99]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=299, Expect=8e-97]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=293, Expect=2e-94]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=290, Expect=7e-92]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=302, Expect=3e-98]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=296, Expect=3e-96]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=291, Expect=5e-94]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=352, Expect=8e-117]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=303, Expect=5e-99]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=424, Expect=2e-146]} {RNA1310_44575} {RNA815_22042} |
56. | MligTC455_18515 | 24 | 0.5 | Mlig455_008323 | Neo: - Age: - |
FARP2 | 0.966 | - | - | - | - | 0.966 | - | Mlig455_008323 {REF} {Length: 4459} {TRANSSPLICED} {Pfam: FERM C-terminal PH-like domain [PF09380.12, score=79.0]; FERM N-terminal domain [PF09379.12, score=61.5]; FERM central domain [PF00373.20, score=47.5]; FERM adjacent (FA) [PF08736.13, score=34.0]} {Human: ENSG00000006607, FARP2, FERM, ARH/RhoGEF and pleckstrin domain protein 2, [RH, Score=326, Expect=5e-99]; ENSG00000152767, FARP1, FERM, ARH/RhoGEF and pleckstrin domain protein 1, [RH, Score=317, Expect=3e-94]} {Mouse: ENSMUSG00000034066, Farp2, FERM, RhoGEF and pleckstrin domain protein 2, [RH, Score=330, Expect=3e-99]} {Dmel: FBgn0265082, Cdep, Chondrocyte-derived ezrin-like domain containing protein, [Score=367, Expect=1e-117]} {Celegans: WBGene00001490, frm-3, FERM domain (Protein4.1-ezrin-radixin-moesin) family, [Score=350, Expect=4e-104]} {Smed: dd_Smed_v6_5600_0_1, dd_Smed_v6_5600_0_1, [Score=433, Expect=5e-131]} {RNA1509_50345} {RNA1310_4844, RNA1509_50345} {RNA1509_50345, RNA815_16713} |
57. | MligTC455_21684 | 5 | 0.11 | Mlig455_014284, Mlig455_014320, Mlig455_014336 | Neo: - Age: logFC(26M/2M)=-0.541 |
HECA | 0.966 | - | 0.966 | - | - | - | - | Mlig455_014284 {REF} {Length: 1986} {Pfam: Headcase protein [PF16002.7, score=201.7]; Headcase protein family homologue [PF15353.8, score=31.7]} {Human: ENSG00000112406, HECA, hdc homolog, cell cycle regulator, [RH, Score=145, Expect=8e-38]} {Mouse: ENSMUSG00000039879, Heca, hdc homolog, cell cycle regulator, [RH, Score=142, Expect=4e-37]} {Dmel: FBgn0010113, hdc, Histidine decarboxylase, [RH, Score=151, Expect=2e-39]} {Celegans: WBGene00010614, cri-1, Conserved Regulator of Innate immunity, [Score=98.2, Expect=1e-22]} {Smed: dd_Smed_v6_6218_0_1, dd_Smed_v6_6218_0_1, [RH, Score=167, Expect=4e-46]} {RNA1509_12340} {RNA1310_16685} {RNA815_9766} Mlig455_014320 {REF} {Length: 2086} {Pfam: Headcase protein [PF16002.7, score=201.7]; Headcase protein family homologue [PF15353.8, score=31.7]} {Human: ENSG00000112406, HECA, hdc homolog, cell cycle regulator, [RH, Score=145, Expect=8e-38]} {Mouse: ENSMUSG00000039879, Heca, hdc homolog, cell cycle regulator, [RH, Score=142, Expect=4e-37]} {Dmel: FBgn0010113, hdc, Histidine decarboxylase, [RH, Score=151, Expect=2e-39]} {Celegans: WBGene00010614, cri-1, Conserved Regulator of Innate immunity, [Score=98.2, Expect=1e-22]} {Smed: dd_Smed_v6_6218_0_1, dd_Smed_v6_6218_0_1, [RH, Score=167, Expect=4e-46]} {RNA1509_12340} {RNA1310_16685, RNA1509_12340} {RNA1509_12340, RNA815_9766} Mlig455_014336 {REF} {Length: 2009} {Pfam: Headcase protein [PF16002.7, score=201.7]; Headcase protein family homologue [PF15353.8, score=31.7]} {Human: ENSG00000112406, HECA, hdc homolog, cell cycle regulator, [RH, Score=145, Expect=7e-38]} {Mouse: ENSMUSG00000039879, Heca, hdc homolog, cell cycle regulator, [RH, Score=142, Expect=4e-37]} {Dmel: FBgn0010113, hdc, Histidine decarboxylase, [RH, Score=151, Expect=2e-39]} {Celegans: WBGene00010614, cri-1, Conserved Regulator of Innate immunity, [Score=98.2, Expect=1e-22]} {Smed: dd_Smed_v6_6218_0_1, dd_Smed_v6_6218_0_1, [RH, Score=166, Expect=6e-46]} {RNA1509_12340} {RNA1310_16685} {RNA815_9766} |
58. | MligTC455_26801 | 7 | 0.14 | Mlig455_024981 | Neo: - Age: - |
0.966 | - | 0.966 | - | - | - | - | Mlig455_024981 {REF} {Length: 847} {RNA1310_42506} {RNA815_41145} | |
59. | MligTC455_37412 | 95 | 1.98 | Mlig455_036605, Mlig455_036645 | Neo: - Age: - |
ADRA2A | 0.966 | - | 0.966 | - | - | - | - | Mlig455_036605 {REF} {Length: 3015} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=97.8]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=55.5, Expect=2e-07]; ENSG00000082556, OPRK1, opioid receptor kappa 1, [Score=55.1, Expect=2e-07]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=56.6, Expect=5e-08]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=64.7, Expect=1e-10]} {Celegans: WBGene00016037, dop-6, DOPamine receptor, [Score=52.4, Expect=7e-07]} {Smed: dd_Smed_v6_23525_0_1, dd_Smed_v6_23525_0_1, [RH, Score=136, Expect=5e-35]} {RNA1310_57451} {RNA815_47300} Mlig455_036645 {REF} {Length: 3203} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=97.0]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=55.5, Expect=2e-07]; ENSG00000082556, OPRK1, opioid receptor kappa 1, [Score=55.1, Expect=1e-07]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=56.6, Expect=4e-08]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=63.2, Expect=4e-10]} {Celegans: WBGene00016037, dop-6, DOPamine receptor, [Score=52.4, Expect=6e-07]} {Smed: dd_Smed_v6_23525_0_1, dd_Smed_v6_23525_0_1, [RH, Score=136, Expect=6e-35]} {RNA1310_57451} {RNA815_47300} |
60. | MligTC455_39587 | 4 | 0.09 | Mlig455_061237 | Neo: - Age: - |
0.966 | - | - | - | - | 0.966 | - | Mlig455_061237 {REF} {Length: 74} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_4093} {RNA1310_1075.1} {RNA815_51104} | |
61. | MligTC455_45398 | 4558 | 94.96 | Mlig455_013975, Mlig455_034998, Mlig455_056737 | Neo: - Age: logFC(26M/2M)=0.327 Region-specific R3: 6.387 Region-enriched R3: 5.675/0.00000 |
0.966 | - | - | - | - | 0.966 | - | Mlig455_013975 {REF} {Length: 868} {RNA1509_20786, RNA1509_4527} {RNA1310_61112.1, RNA1509_20786, RNA1509_4527} {RNA1509_20786, RNA1509_4527, RNA815_31397} Mlig455_034998 {REF} {Length: 583} {TRANSSPLICED} {RNA1509_4527} {RNA1310_61112.1} {RNA815_31397} Mlig455_056737 {REF} {Length: 855} {RNA1509_4527} {RNA1310_61112.1} {RNA815_31397} |
|
62. | MligTC455_47927 | 43 | 0.9 | Mlig455_029720 | Neo: - Age: - |
0.966 | - | 0.966 | - | - | - | - | Mlig455_029720 {REF} {Length: 2459} {RNA1509_35671} {RNA1310_75812} {RNA815_33002} | |
63. | MligTC455_47997 | 36 | 0.75 | Mlig455_053262, Mlig455_065031 | Neo: - Age: - |
0.966 | - | 0.966 | - | - | - | - | Mlig455_053262 {REF} {Length: 927} {RNA1310_55950} {RNA815_42062.2} Mlig455_065031 {REF} {Length: 926} {RNA1310_55950} {RNA815_42062.2} |
|
64. | MligTC455_10227 | 76 | 1.59 | Mlig455_023507, Mlig455_023516, Mlig455_023551 | Neo: - Age: - |
0.965 | - | 0.965 | - | - | - | - | Mlig455_023507 {REF} {Length: 1545} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=21.8]} {RNA1310_22533.3} {RNA815_23050} Mlig455_023516 {REF} {Length: 1641} {RNA1310_22533.3} {RNA815_23050} Mlig455_023551 {REF} {Length: 1638} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.2]} {RNA1310_22533.3} {RNA815_26724.1} |
|
65. | MligTC455_12116 | 106 | 2.2 | Mlig455_004661, Mlig455_004728 | Neo: - Age: Up-Up-Down |
0.965 | - | 0.965 | - | - | - | - | Mlig455_004661 {REF} {Length: 3441} {RNA1509_48407} {RNA1310_2938.1} {RNA815_14343.2} Mlig455_004728 {REF} {Length: 2670} {RNA1509_48407} {RNA1310_45267.1, RNA1509_48407} {RNA1509_48407, RNA815_58661} |
|
66. | MligTC455_34233 | 101 | 2.11 | Mlig455_053145 | Neo: - Age: Down-Up-Down |
ACR | 0.965 | - | - | - | - | 0.965 | - | Mlig455_053145 {REF} {Length: 1245} {Pfam: Trypsin [PF00089.28, score=175.3]} {Human: ENSG00000100312, ACR, acrosin, [Score=161, Expect=1e-45]; ENSG00000283539, ACR, acrosin, [Score=161, Expect=1e-45]; ENSG00000122194, PLG, plasminogen, [Score=156, Expect=8e-42]; ENSG00000198670, LPA, lipoprotein(a), [Score=155, Expect=2e-41]; ENSG00000178297, TMPRSS9, transmembrane serine protease 9, [Score=154, Expect=3e-41]} {Mouse: ENSMUSG00000059481, Plg, plasminogen, [Score=152, Expect=1e-40]; ENSMUSG00000059406, Tmprss9, transmembrane protease, serine 9, [Score=151, Expect=4e-40]; ENSMUSG00000016942, Tmprss6, transmembrane serine protease 6, [Score=149, Expect=1e-39]; ENSMUSG00000033177, Tmprss7, transmembrane serine protease 7, [Score=145, Expect=4e-38]} {Dmel: FBgn0036287, CG10663, [Score=132, Expect=6e-34]} {Celegans: WBGene00006619, try-1, TRYpsin-like protease, [Score=125, Expect=2e-33]} {Smed: dd_Smed_v6_2492_0_1, dd_Smed_v6_2492_0_1, [Score=175, Expect=3e-52]} {RNA1509_37786} {RNA1310_26421} {RNA815_13601} |
67. | MligTC455_04073 | 3 | 0.07 | Mlig455_005595 | Neo: - Age: - |
0.964 | - | - | - | - | 0.964 | - | Mlig455_005595 {REF} {Length: 604} {NoTransDecoderORF} {RNA1509_19566} {RNA1310_121704} {RNA815_49429} | |
68. | MligTC455_10148 | 2 | 0.05 | Mlig455_047545 | Neo: - Age: - |
0.964 | - | - | - | - | 0.964 | - | Mlig455_047545 {REF} {Length: 365} {NoTransDecoderORF} {RNA1310_36688} | |
69. | MligTC455_12388 | 25 | 0.52 | Mlig455_000936 | Neo: - Age: - |
SETMAR | 0.964 | - | - | - | - | 0.964 | - | Mlig455_000936 {REF} {Length: 2242} {Pfam: Transposase (partial DDE domain) [PF01359.20, score=48.4]; DDE superfamily endonuclease [PF13358.8, score=29.0]; Homeodomain-like domain [PF13565.8, score=24.2]; Transposase [PF01498.20, score=21.1]; Winged helix-turn helix [PF13551.8, score=19.9]} {Human: ENSG00000170364, SETMAR, SET domain and mariner transposase fusion gene, [Score=167, Expect=3e-45]} {Smed: dd_Smed_v6_52102_0_1, dd_Smed_v6_52102_0_1, [Score=69.7, Expect=1e-14]} {RNA1310_28836.1} {RNA815_34045} |
70. | MligTC455_14856 | 14 | 0.29 | Mlig455_023184 | Neo: - Age: - |
ANGPTL7 | 0.964 | - | - | - | - | 0.964 | - | Mlig455_023184 {REF} {Length: 1290} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=129.4]; PAN domain [PF00024.28, score=23.8]} {Human: ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=105, Expect=1e-25]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=103, Expect=3e-24]} {Mouse: ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=104, Expect=1e-25]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=102, Expect=4e-24]} {Dmel: FBgn0033312, CG8642, [Score=96.7, Expect=2e-22]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=98.6, Expect=5e-23]} {RNA1509_58115} {RNA1310_36699.1} {RNA815_17918.1} |
71. | MligTC455_16054 | 25 | 0.52 | Mlig455_031933 | Neo: - Age: - |
0.964 | - | - | - | - | 0.964 | - | Mlig455_031933 {REF} {Length: 666} {RNA1310_71129.1} {RNA815_34113} | |
72. | MligTC455_20383 | 6 | 0.13 | Mlig455_032633 | Neo: - Age: - |
0.964 | - | - | - | - | 0.964 | - | Mlig455_032633 {REF} {Length: 392} {RNA1509_48296} {RNA1310_86641} {RNA815_40392} | |
73. | MligTC455_41374 | 23 | 0.49 | Mlig455_008163 | Neo: - Age: - |
0.964 | - | - | - | - | 0.964 | - | Mlig455_008163 {REF} {Length: 715} {RNA1310_116941} | |
74. | MligTC455_43884 | 6 | 0.12 | Mlig455_044330 | Neo: - Age: - |
0.964 | - | - | - | - | 0.964 | - | Mlig455_044330 {REF} {Length: 1140} {Pfam: Presenilin [PF01080.19, score=18.9]; Velvet factor [PF11754.10, score=18.9]} | |
75. | MligTC455_10226 | 119 | 2.48 | Mlig455_023508, Mlig455_023518, Mlig455_023617 | Neo: - Age: - |
0.963 | - | 0.963 | - | - | - | - | Mlig455_023508 {REF} {Length: 1311} {RNA1310_22533.2} {RNA815_23050} Mlig455_023518 {REF} {Length: 1413} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=21.5]} {RNA1310_22533.2} {RNA815_23050} Mlig455_023617 {REF} {Length: 1414} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.6]} {RNA1310_22533.2} {RNA815_23050} |
|
76. | MligTC455_10228 | 50 | 1.05 | Mlig455_023553 | Neo: - Age: - |
0.963 | - | 0.963 | - | - | - | - | Mlig455_023553 {REF} {Length: 1195} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=20.0]} {RNA1310_22533.1} {RNA815_23050} | |
77. | MligTC455_12484 | 808 | 16.84 | Mlig455_054887 | Neo: - Age: Up-Down-Down Region-enriched R2: 2.064/0.02321 |
LTBP2 | 0.963 | - | - | - | - | 0.963 | - | Mlig455_054887 {REF} {Length: 5896} {Pfam: Calcium-binding EGF domain [PF07645.17, score=86.1]; Complement Clr-like EGF-like [PF12662.9, score=59.0]; EGF-like domain [PF00008.29, score=26.1]; Human growth factor-like EGF [PF12661.9, score=20.0]; Coagulation Factor Xa inhibitory site [PF14670.8, score=19.9]} {Human: ENSG00000119681, LTBP2, latent transforming growth factor beta binding protein 2, [Score=149, Expect=2e-35]; ENSG00000049323, LTBP1, latent transforming growth factor beta binding protein 1, [Score=142, Expect=3e-33]} {Mouse: ENSMUSG00000002020, Ltbp2, latent transforming growth factor beta binding protein 2, [Score=141, Expect=5e-33]; ENSMUSG00000024598, Fbn2, fibrillin 2, [Score=141, Expect=5e-33]; ENSMUSG00000040488, Ltbp4, latent transforming growth factor beta binding protein 4, [Score=137, Expect=6e-32]; ENSMUSG00000027204, Fbn1, fibrillin 1, [Score=136, Expect=1e-31]} {Dmel: FBgn0035798, frac, faulty attraction, [Score=122, Expect=2e-27]} {Celegans: WBGene00022816, fbn-1, FBN-1A.1; FiBrilliN homolog, [Score=108, Expect=4e-23]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=121, Expect=3e-27]} {RNA1509_52818} {RNA1310_702.1, RNA1509_52818} {RNA1509_52818, RNA815_201.1} |
78. | MligTC455_19821 | 40 | 0.84 | Mlig455_010217 | Neo: - Age: - |
0.963 | - | - | - | - | 0.963 | - | Mlig455_010217 {REF} {Length: 1747} {NoTransDecoderORF} {RNA1310_66243} | |
79. | MligTC455_46281 | 22 | 0.45 | Mlig455_016138 | Neo: Irradiation Age: - |
KDELR2 | 0.963 | - | 0.963 | - | - | - | - | Mlig455_016138 {REF} {Length: 2664} {TRANSSPLICED} {Pfam: ER lumen protein retaining receptor [PF00810.20, score=173.9]; Intermediate filament protein [PF00038.23, score=132.5]; Lamin Tail Domain [PF00932.21, score=37.2]} {Human: ENSG00000136240, KDELR2, KDEL endoplasmic reticulum protein retention receptor 2, [Score=293, Expect=2e-93]} {Mouse: ENSMUSG00000079111, Kdelr2, KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2, [Score=296, Expect=1e-94]} {Dmel: FBgn0267330, KdelR, KDEL receptor, [Score=291, Expect=4e-93]} {Celegans: WBGene00001331, erd-2, ER lumen protein-retaining receptor, [Score=266, Expect=2e-83]} {Smed: dd_Smed_v6_1592_0_1, dd_Smed_v6_1592_0_1, [Score=283, Expect=8e-90]} {RNA1509_3479} {RNA1310_8292} {RNA815_3092.1} |
80. | MligTC455_17266 | 62 | 1.3 | Mlig455_043650 | Neo: - Age: - |
0.962 | - | 0.962 | - | - | - | - | Mlig455_043650 {REF} {Length: 2826} {RNA1310_48878} {RNA815_25527} | |
81. | MligTC455_17394 | 41 | 0.85 | Mlig455_013077 | Neo: - Age: - |
0.962 | - | 0.962 | - | - | - | - | Mlig455_013077 {REF} {Length: 1066} {RNA1310_66954} {RNA815_27868} | |
82. | MligTC455_49922 | 36 | 0.76 | Mlig455_049338 | Neo: - Age: Down-Down-Up Region-enriched R2: 7.622/0.00496 |
0.962 | - | 0.962 | - | - | - | - | Mlig455_049338 {REF} {Length: 971} {RNA1310_37449} {RNA815_3585} | |
83. | MligTC455_53658 | 41 | 0.86 | Mlig455_070698 | Neo: - Age: Up-Down-Down Region-enriched R2: 9.084/0.01491 |
0.962 | - | 0.962 | - | - | - | - | Mlig455_070698 {REF} {Length: 1026} {RNA1509_40972} {RNA1310_35649.1} {RNA815_17004} | |
84. | MligTC455_41443 | 382 | 7.96 | Mlig455_034791, Mlig455_034803 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-1.360 Region-enriched R2: 5.869/0.00205 |
0.961 | - | 0.961 | - | - | - | - | Mlig455_034791 {REF} {Length: 996} {RNA1310_39610.1} {RNA815_26421} Mlig455_034803 {REF} {Length: 1084} {RNA1310_39610.1} {RNA815_26421} |
|
85. | MligTC455_05753 | 20 | 0.43 | Mlig455_046443, Mlig455_046475 | Neo: - Age: - |
0.96 | - | - | - | - | 0.960 | - | Mlig455_046443 {REF} {Length: 1972} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=89.6]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=47.0]; Taste receptor protein (TAS2R) [PF05296.15, score=25.1]} {Dmel: FBgn0264002, MsR2, Myosuppressin receptor 2, [Score=86.3, Expect=8e-18]} {Celegans: WBGene00016428, dmsr-7, DroMyoSuppressin Receptor related, [Score=84.7, Expect=1e-17]} {Smed: dd_Smed_v6_17590_0_1, dd_Smed_v6_17590_0_1, [Score=141, Expect=9e-38]} {RNA1310_111897} Mlig455_046475 {REF} {Length: 1474} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=90.2]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=46.5]; Taste receptor protein (TAS2R) [PF05296.15, score=24.9]} {Dmel: FBgn0264002, MsR2, Myosuppressin receptor 2, [Score=86.7, Expect=7e-18]} {Celegans: WBGene00016428, dmsr-7, DroMyoSuppressin Receptor related, [Score=85.5, Expect=7e-18]} {Smed: dd_Smed_v6_17590_0_1, dd_Smed_v6_17590_0_1, [Score=142, Expect=1e-37]} {RNA1310_111897} |
|
86. | MligTC455_06288 | 3 | 0.06 | Mlig455_011062 | Neo: - Age: - |
GRM7 | 0.96 | - | - | - | - | 0.960 | - | Mlig455_011062 {REF} {Length: 3433} {Pfam: Receptor family ligand binding region [PF01094.30, score=284.5]; 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=180.4]; Nine Cysteines Domain of family 3 GPCR [PF07562.16, score=39.5]; Periplasmic binding protein [PF13458.8, score=30.5]} {Human: ENSG00000196277, GRM7, glutamate metabotropic receptor 7, [RH, Score=719, Expect=0.0]; ENSG00000179603, GRM8, glutamate metabotropic receptor 8, [RH, Score=695, Expect=0.0]; ENSG00000124493, GRM4, glutamate metabotropic receptor 4, [RH, Score=686, Expect=0.0]} {Mouse: ENSMUSG00000056755, Grm7, glutamate receptor, metabotropic 7, [RH, Score=718, Expect=0.0]; ENSMUSG00000024211, Grm8, glutamate receptor, metabotropic 8, [RH, Score=699, Expect=0.0]; ENSMUSG00000063239, Grm4, glutamate receptor, metabotropic 4, [RH, Score=697, Expect=0.0]; ENSMUSG00000003974, Grm3, glutamate receptor, metabotropic 3, [RH, Score=686, Expect=0.0]} {Dmel: FBgn0019985, mGluR, metabotropic Glutamate Receptor, [Score=678, Expect=0.0]} {Celegans: WBGene00021152, mgl-3, Metabotropic GLutamate receptor family, [RH, Score=630, Expect=0.0]} {Smed: dd_Smed_v6_15419_0_1, dd_Smed_v6_15419_0_1, [Score=608, Expect=0.0]} {RNA1509_26392} {RNA1310_51256} {RNA815_24071} |
87. | MligTC455_51304 | 78 | 1.63 | Mlig455_027579 | Neo: - Age: - |
CTSA | 0.96 | - | - | - | - | 0.960 | - | Mlig455_027579 {REF} {Length: 3047} {Pfam: Serine carboxypeptidase [PF00450.24, score=324.1]} {Human: ENSG00000064601, CTSA, cathepsin A, [Score=178, Expect=3e-48]} {Mouse: ENSMUSG00000017760, Ctsa, cathepsin A, [Score=175, Expect=2e-47]} {Dmel: FBgn0038738, CG4572, [RH, Score=120, Expect=8e-29]} {Celegans: WBGene00019605, ctsa-1, Uncharacterized serine carboxypeptidase ctsa-1, [Score=197, Expect=6e-56]} {Smed: dd_Smed_v6_785_0_1, dd_Smed_v6_785_0_1, [Score=203, Expect=1e-57]} {RNA1310_57245} {RNA815_58201} |
88. | MligTC455_52527 | 28 | 0.58 | Mlig455_025836 | Neo: - Age: - |
FLVCR2 | 0.96 | - | 0.960 | - | - | - | - | Mlig455_025836 {REF} {Length: 2177} {TRANSSPLICED} {Pfam: Major Facilitator Superfamily [PF07690.18, score=81.4]; Sugar (and other) transporter [PF00083.26, score=18.7]} {Human: ENSG00000119686, FLVCR2, feline leukemia virus subgroup C cellular receptor family member 2, [RH, Score=364, Expect=5e-119]} {Mouse: ENSMUSG00000034258, Flvcr2, feline leukemia virus subgroup C cellular receptor 2, [RH, Score=367, Expect=3e-120]} {Dmel: FBgn0033196, CG1358, [RH, Score=350, Expect=1e-114]} {Celegans: WBGene00015632, C09D4.1, Uncharacterized MFS-type transporter C09D4.1, [RH, Score=358, Expect=1e-116]} {Smed: dd_Smed_v6_7578_0_1, dd_Smed_v6_7578_0_1, [Score=335, Expect=3e-109]} {RNA1509_31725} {RNA1310_8852.1} {RNA815_14234} |
89. | MligTC455_08407 | 22 | 0.46 | Mlig455_043162 | Neo: - Age: - |
0.959 | - | 0.959 | - | - | - | - | Mlig455_043162 {REF} {Length: 1257} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=20.7]} {RNA1310_58288} {RNA815_55196} | |
90. | MligTC455_11780 | 35 | 0.73 | Mlig455_023335 | Neo: - Age: Down-Up-Down Regeneration-enriched R4: 10.634 |
PDE9A | 0.959 | - | - | - | - | 0.959 | - | Mlig455_023335 {REF} {Length: 3554} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=286.3]} {Human: ENSG00000160191, PDE9A, phosphodiesterase 9A, [Score=544, Expect=0.0]} {Mouse: ENSMUSG00000041119, Pde9a, phosphodiesterase 9A, [Score=549, Expect=0.0]} {Dmel: FBgn0259171, Pde9, Phosphodiesterase 9, [Score=311, Expect=8e-92]} {Celegans: WBGene00020114, pde-4, Probable 3',5'-cyclic phosphodiesterase pde-4, [Score=163, Expect=4e-43]} {Smed: dd_Smed_v6_13304_0_1, dd_Smed_v6_13304_0_1, [Score=298, Expect=3e-93]} {RNA1310_14570} {RNA815_20478} |
91. | MligTC455_15664 | 15 | 0.31 | Mlig455_005748 | Neo: - Age: - |
0.959 | - | - | - | - | 0.959 | - | Mlig455_005748 {REF} {Length: 1088} {RNA1509_51462} {RNA1310_127079} {RNA815_42143} | |
92. | MligTC455_18140 | 171 | 3.56 | Mlig455_033232 | Neo: - Age: Up-Down-Down Region-specific R2: 6.925 Region-enriched R2: 6.274/0.02921 |
TRPC5 | 0.959 | - | 0.959 | - | - | - | - | Mlig455_033232 {REF} {Length: 4524} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.2]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.5]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=742, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=745, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=742, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=696, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1016, Expect=0.0]} {RNA1509_34138} {RNA1310_12839} {RNA815_17637} |
93. | MligTC455_25485 | 167 | 3.48 | Mlig455_030724 | Neo: - Age: Up-Up-Down |
GABBR1 | 0.959 | - | - | - | - | 0.959 | - | Mlig455_030724 {REF} {Length: 4167} {Human: ENSG00000204681, GABBR1, gamma-aminobutyric acid type B receptor subunit 1, [Score=76.3, Expect=3e-15]; ENSG00000232632, GABBR1, gamma-aminobutyric acid type B receptor subunit 1, [Score=76.3, Expect=3e-15]; ENSG00000237051, GABBR1, gamma-aminobutyric acid type B receptor subunit 1, [Score=76.3, Expect=3e-15]; ENSG00000206511, GABBR1, gamma-aminobutyric acid type B receptor subunit 1, [Score=76.3, Expect=3e-15]; ENSG00000206466, GABBR1, gamma-aminobutyric acid type B receptor subunit 1, [Score=76.3, Expect=3e-15]; ENSG00000232569, GABBR1, gamma-aminobutyric acid type B receptor subunit 1, [Score=76.3, Expect=3e-15]; ENSG00000237112, GABBR1, gamma-aminobutyric acid type B receptor subunit 1, [Score=76.3, Expect=3e-15]} {Mouse: ENSMUSG00000024462, Gabbr1, gamma-aminobutyric acid (GABA) B receptor, 1, [Score=76.3, Expect=2e-15]} {Dmel: FBgn0260446, GABA-B-R1, metabotropic GABA-B receptor subtype 1, [Score=108, Expect=1e-26]} {Celegans: WBGene00021528, gbb-1, GABA B receptor subunit; GABAB1 receptor subunit, [Score=74.3, Expect=6e-16]} {Smed: dd_Smed_v6_20665_0_2, dd_Smed_v6_20665_0_2, [Score=79.7, Expect=8e-18]} {RNA1509_21092} {RNA1310_7011.2} {RNA815_9475} |
94. | MligTC455_35000 | 20 | 0.42 | Mlig455_050562 | Neo: - Age: - |
KCNC1 | 0.959 | - | 0.959 | - | - | - | - | Mlig455_050562 {REF} {Length: 3042} {Pfam: Ion transport protein [PF00520.33, score=116.8]; BTB/POZ domain [PF02214.24, score=75.0]; Ion channel [PF07885.18, score=42.0]} {Human: ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=211, Expect=2e-60]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=209, Expect=1e-58]; ENSG00000182674, KCNB2, potassium voltage-gated channel subfamily B member 2, [Score=206, Expect=3e-56]; ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=204, Expect=3e-57]; ENSG00000158445, KCNB1, potassium voltage-gated channel subfamily B member 1, [Score=204, Expect=1e-55]; ENSG00000131398, KCNC3, potassium voltage-gated channel subfamily C member 3, [Score=203, Expect=7e-56]} {Mouse: ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=212, Expect=3e-60]; ENSMUSG00000050556, Kcnb1, potassium voltage gated channel, Shab-related subfamily, member 1, [Score=209, Expect=2e-57]; ENSMUSG00000092083, Kcnb2, potassium voltage gated channel, Shab-related subfamily, member 2, [Score=206, Expect=2e-56]; ENSMUSG00000027895, Kcnc4, potassium voltage gated channel, Shaw-related subfamily, member 4, [Score=204, Expect=4e-57]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=203, Expect=1e-56]; ENSMUSG00000062785, Kcnc3, potassium voltage gated channel, Shaw-related subfamily, member 3, [Score=203, Expect=4e-56]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=223, Expect=2e-65]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=224, Expect=8e-65]} {Smed: dd_Smed_v6_20858_0_1, dd_Smed_v6_20858_0_1, [RH, Score=567, Expect=0.0]} {RNA1509_22940} {RNA1310_28483} {RNA815_31040} |
95. | MligTC455_46760 | 3368 | 70.16 | Mlig455_000096 | Neo: - Age: - |
SLC1A2 | 0.958 | - | - | - | - | 0.958 | - | Mlig455_000096 {REF} {Length: 3406} {Pfam: Sodium:dicarboxylate symporter family [PF00375.20, score=428.1]} {Human: ENSG00000110436, SLC1A2, solute carrier family 1 member 2, [RH, Score=535, Expect=0.0]} {Mouse: ENSMUSG00000005089, Slc1a2, solute carrier family 1 (glial high affinity glutamate transporter), member 2, [RH, Score=547, Expect=0.0]} {Dmel: FBgn0026439, Eaat1, Excitatory amino acid transporter 1, [RH, Score=382, Expect=6e-127]} {Celegans: WBGene00001620, glt-1, Excitatory amino acid transporter, [RH, Score=530, Expect=0.0]} {Smed: dd_Smed_v6_7570_0_1, dd_Smed_v6_7570_0_1, [RH, Score=607, Expect=0.0]} {RNA1509_2356, RNA1509_47494} {RNA1310_5021.1, RNA1509_2356, RNA1509_47494} {RNA1509_2356, RNA1509_47494, RNA815_1444.1} |
96. | MligTC455_15884 | 26 | 0.54 | Mlig455_066451 | Neo: - Age: - Region-enriched R2: 9.632/0.00394 |
0.957 | - | 0.957 | - | - | - | - | Mlig455_066451 {REF} {Length: 1468} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=20.9]} {RNA1310_27849} {RNA815_37376} | |
97. | MligTC455_17479 | 32 | 0.66 | Mlig455_032081, Mlig455_070278 | Neo: - Age: logFC(26M/2M)=-0.516 |
CHRNA3 | 0.957 | - | 0.957 | - | - | - | - | Mlig455_032081 {REF} {Length: 2787} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=230.7]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.4]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=368, Expect=1e-121]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=5e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=6e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=361, Expect=3e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=381, Expect=3e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=614, Expect=0.0]} {RNA1509_28642} {RNA1310_34709} {RNA815_44960} Mlig455_070278 {REF} {Length: 2270} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=232.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.2]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=369, Expect=7e-122]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=4e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=9e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=362, Expect=1e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=382, Expect=2e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=616, Expect=0.0]} {RNA1509_16247} {RNA1310_34709} {RNA815_44960} |
98. | MligTC455_25371 | 13 | 0.26 | Mlig455_014547, Mlig455_014550 | Neo: - Age: Up-Down-Up |
NCAM2 | 0.957 | - | - | - | - | 0.957 | - | Mlig455_014547 {REF} {Length: 1183} {Pfam: Integrase zinc binding domain [PF17921.3, score=56.1]} {RNA1509_45000} {RNA1310_89740} Mlig455_014550 {REF} {Length: 5582} {TRANSSPLICED} {Pfam: Immunoglobulin domain [PF13927.8, score=102.0]; Immunoglobulin I-set domain [PF07679.18, score=80.2]; Immunoglobulin domain [PF13895.8, score=71.6]; Immunoglobulin domain [PF00047.27, score=52.0]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=43.9]; Immunoglobulin V-set domain [PF07686.19, score=29.5]} {Human: ENSG00000154654, NCAM2, neural cell adhesion molecule 2, [Score=122, Expect=3e-28]} {Mouse: ENSMUSG00000022762, Ncam2, neural cell adhesion molecule 2, [Score=115, Expect=3e-26]} {Dmel: FBgn0033159, Dscam1, Down syndrome cell adhesion molecule 1, [Score=60.8, Expect=4e-09]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=70.1, Expect=4e-12]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=53.9, Expect=3e-07]} {RNA1509_40266} {RNA1310_7040} {RNA815_17849} |
99. | MligTC455_30634 | 114 | 2.38 | Mlig455_025888 | Neo: - Age: Up-Down-Up Region-enriched R2: 6.750/0.00140 |
0.957 | - | 0.957 | - | - | - | - | Mlig455_025888 {REF} {Length: 5266} {Pfam: Integrase core domain [PF00665.28, score=50.8]; DDE superfamily endonuclease [PF13358.8, score=22.0]} {Smed: dd_Smed_v6_1574_6_72, dd_Smed_v6_1574_6_72, [Score=149, Expect=3e-41]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_6291.1} | |
100. | MligTC455_07023 | 32 | 0.67 | Mlig455_018609 | Neo: - Age: - |
TMEM243 | 0.956 | - | - | - | - | 0.956 | - | Mlig455_018609 {REF} {Length: 1106} {TRANSSPLICED} {Pfam: Protein of unknown function (DUF2678) [PF10856.10, score=53.8]} {Human: ENSG00000135185, TMEM243, transmembrane protein 243, [RH, Score=64.7, Expect=5e-13]} {Mouse: ENSMUSG00000079659, Tmem243, transmembrane protein 243, mitochondrial, [Score=49.3, Expect=1e-07]} {RNA1509_52894} {RNA1310_40265} {RNA815_19809} |